Philips
Philips is a global health technology company based in the Netherlands, dedicated to enhancing health and well-being through meaningful innovation. The company operates in three main segments: diagnosis and treatment, connected care, and personal health. Its diagnosis and treatment segment, which generates nearly half of its revenue, includes advanced imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment focuses on monitoring and analytics systems for hospitals and encompasses sleep and respiratory care. Additionally, the personal health segment offers a range of products related to oral health and personal grooming. Philips has a strong commitment to research and development, aiming to introduce innovative solutions that address critical health areas such as radiology, cardiology, and oncology, thereby improving patient outcomes across the health continuum from prevention to home care. Established in 1891, Philips continues to evolve as a leader in healthcare technology, impacting lives worldwide.
Noninvasix, Inc. (the “Company” or “Noninvasix”) is a medical technology company that has developed a novel solution to non-invasively monitor for the first time, oxygen sufficiency in organs and veins. The Company was founded in 2007 by Dr. Donald Prough and Dr. Rinat Esenaliev at the University of Texas Medical Branch (UTMB) and is based out of Houston, Texas. The Company has raised over $6.8 million to date including a seed round in Q4 2021. The platform technology of the Company has been developed with $6 million in grants from the NIH and DOD. The Company has also been a part of prestigious accelerator programs such as Philips Healthworks, TMCx, JLabs, Health Wildcatters and has won multiple awards for their innovation. The non-invasive technology has been clinically validated in multiple peer-reviewed journals. The IP portfolio of the Company includes 9 U.S. and 8 global patents.
Medumo is a healthcare statrtup that helps healthcare organizations deliver the right instructions to the right patients at the right time using automated SMS and email. The company combines technologies in mobile communication and artificial intelligence to equip providers with the capability to engage their patients more without more time or money. It also empowers patients by giving them the right information at precisely the time of need. Its ultimate vision is a more transparent, knowledgeable and healthy world.
Xealth Inc. operates a digital health prescribing platform that allows clinicians to integrate, prescribe, and monitor digital health tools directly from electronic health record (EHR) workflows. Founded in 2016 and based in Seattle, Washington, the platform facilitates patient engagement by enabling care teams to order appropriate digital health tools and programs, which can be sent to patients via email or patient portals. In addition to managing digital health prescriptions, the platform supports patient education and offers non-clinical services such as ride shares and food delivery. This comprehensive approach allows clinicians to monitor patient activity and engagement, ultimately enhancing the overall effectiveness of digital health initiatives within healthcare systems.
Non Equity Assistance in 2018
LinkingMed Inc. specializes in developing an oncology data analysis platform designed to assist medical institutions and hospitals in evaluating cancer and tumor data. The platform enables doctors, researchers, and medical physicists to analyze oncology data and accurately identify cancer locations within medical imaging. This capability allows medical professionals to review treatment plans digitally and determine suitable cancer treatments. LinkingMed also provides AI and cloud-based solutions for organ contouring, target delineation, automatic planning, and radiotherapy quality assurance tools and services, catering to radiotherapy departments and third-party medical imaging centers. The company maintains long-term strategic collaborations with both domestic and international research and clinical institutions and has secured multiple national scientific grants, working alongside notable organizations such as the National Institutes of Health and Harvard Medical School.
OBMedical Company specializes in the development, manufacture, and sale of external maternal-fetal monitoring systems designed for laboring women. The company's flagship product, the LaborView sensor system, is a wireless electrode-based device that measures labor contractions and monitors the heart rates of both mothers and infants. This innovative system allows for greater mobility during labor by providing signal capture and digital signal processing. By enhancing the accuracy and comfort of monitoring, OBMedical aims to improve health outcomes and safety for mothers and their babies during pregnancy and labor. Founded in 2012 and headquartered in Newberry, Florida, with an additional office in Norcross, Georgia, OBMedical was sold to Philips Healthcare in late 2018. The technology behind the LaborView system was developed in collaboration with the University of Florida and Convergent Engineering, making it a significant advancement in obstetric care.
EPD Solutions (EPD), a member of the Hobart Group companies, is dedicated to improving the efficacy and efficiency of minimally invasive catheter-based procedures performed to treat cardiac arrhythmias.
ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placed within the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein. The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.